Catatan efek · kuartal yang diarsipkan
ABUS
Arbutus Biopharma Corp · Healthcare · Biotechnology
16Pemegang yang dilacak
0Δ pemegang
63.04MSaham yang dipegang
$286.21MNilai yang dilaporkan
+1Posisi baru
−1Keluar
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +3.6% · posisi baru bersih 0.0% — formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | +3 | 78.82M | $378.29M | +13 | −10 |
| Q1 2026 | 75 | -5 | 80.64M | $362.88M | +5 | −10 |
| Q4 2025 | 79 | -1 | 77.73M | $373.87M | — | −1 |
| Q3 2025 | 16 | 0 | 63.04M | $286.21M | +1 | −1 |
| Q2 2025 | 13 | +1 | 34.03M | $105.14M | +1 | — |
| Q1 2025 | 9 | 0 | 10.62M | $37.08M | — | — |
| Q4 2024 | 9 | 0 | 11.43M | $37.37M | — | — |
| Q3 2024 | 8 | +1 | 7.82M | $30.10M | +1 | — |
| Q2 2024 | 7 | — | 7.20M | $22.26M | — | — |
Siapa yang memegangnya · Q3 2025
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasif) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (pasif) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (pasif) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (pasif) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (pasif) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (pasif) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (pasif) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (pasif) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | BlackRock ✦ (pasif) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | BlackRock ✦ (pasif) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (pasif) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | The Vanguard Group ✦ (pasif) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | The Vanguard Group ✦ (pasif) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | The Vanguard Group ✦ (pasif) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | The Vanguard Group ✦ (pasif) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | Adage Capital Partners ✦ | 5.01M | +94.7% | $22.77M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | State Street Global Advisors ✦ (pasif) | 4.10M | -8.1% | $18.61M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | Geode Capital Management ✦ (pasif) | 3.67M | +0.8% | $16.65M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | Geode Capital Management ✦ (pasif) | 3.67M | +0.8% | $16.65M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | Goldman Sachs Group ✦ | 2.17M | — | $9.87M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Goldman Sachs Group ✦ | 2.17M | — | $9.87M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Millennium Management ✦ | 528.34K | +5.8% | $2.40M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 30 | Wellington Management ✦ | 514.08K | -3.3% | $2.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 31 | Wellington Management ✦ | 514.08K | -3.3% | $2.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 32 | Wellington Management ✦ | 514.08K | -3.3% | $2.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Citadel Advisors ✦ | 193.69K | +61.0% | $879,357 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 44 | D. E. Shaw & Co. ✦ | 189.95K | +366.7% | $862,382 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 45 | D. E. Shaw & Co. ✦ | 189.95K | +366.7% | $862,382 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 46 | Arrowstreet Capital ✦ | 159.12K | Baru | $722,396 | 0.0% | New | 1 | SEC ↗ |
| 47 | Fidelity (FMR) ✦ | 89.46K | +10.8% | $406,165 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 48 | Fidelity (FMR) ✦ | 89.46K | +10.8% | $406,165 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 49 | T. Rowe Price ✦ | 83.01K | +8.5% | $377,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 54 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Arrowstreet Capital | $722,396 | 0.0% |
Telah keluar
| Two Sigma Investments | $34,914 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 166 pemegang, 138.84M saham, $623.91M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q3 2025 ·
Metodologi ·
Dapatkan ini melalui API